Melanotan-II is a cyclic synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), shortened and constrained into a ring for stability and potency at melanocortin receptors in research systems. Its cyclic architecture is the defining structural feature that distinguishes it from the linear native hormone.
Lactam-bridged ring
A side-chain-to-side-chain lactam bond cyclizes the peptide, locking a bioactive conformation and resisting the linear degradation that limits native alpha-MSH. This conformational constraint is what feeds its mechanism of action as a durable melanocortin-receptor probe. Cyclization as a stabilization strategy is a recurring theme in peptide chemistry.
From alpha-MSH to analog
The design retains the core message sequence of alpha-MSH — the residues responsible for melanocortin-receptor recognition — while cyclizing and substituting key positions to improve stability and potency. The same conceptual core later inspired the related, more receptor-selective PT-141.
Why cyclization matters
Linear peptides are readily cleaved by exopeptidases at their termini; a lactam ring removes the free ends and rigidifies the backbone, extending the molecule's functional lifetime in assay media. The general logic of how sequence and modification define a peptide is covered in understanding amino acid sequences.
Assembly and cyclization
Melanotan-II is built by solid-phase peptide synthesis, after which the lactam bridge is formed to cyclize the chain. The peptide is then cleaved, purified, and lyophilized (what is lyophilization) into a stable research powder.
Verification
Identity and purity are confirmed by HPLC purity analysis and mass spectrometry, which together verify both composition and successful cyclization. Its origin is described in melanotan-II discovery and history.
Cyclization quality control
Successful assembly of the linear precursor does not by itself confirm formation of the intended lactam ring. Cyclization conditions must favor the desired intramolecular bond over intermolecular products or incompletely reacted material. Chromatography removes these species, while mass analysis confirms composition; additional orthogonal characterization may be used when the precise ring closure must be demonstrated.
Structure as a selectivity variable
Constraining the alpha-MSH pharmacophore improves stability but does not make MT-2 selective for one melanocortin receptor subtype. The same compact presentation can engage multiple family members. Researchers should therefore distinguish chemical integrity from pharmacological selectivity: a correctly synthesized, highly pure cyclic peptide can still be intentionally broad in receptor activity.
Product page: Melanotan-II research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.